Calcineurin can work cooperatively with Aβ or tau and contribute to the loss of dendritic spines and synapses, leading to cognitive deficit in mouse models of AD, thus use of calcineurin inhibitors can reverse or improve these impairments [5, 132]. The gene discussed is MAPT; the disease is Alzheimer disease.